A Los Angeles jury on March 25 found Meta and YouTube liable for harming a young woman through the addictive design of their ...

Violent clashes erupted between Newcastle and Sunderland supporters ahead of the Tyne-Wear derby match this afternoon, with ...

Communities across the country are grappling with how to handle sexual assault allegations against Hispanic labor icon Cesar Chavez.Earlier this week, survivors alleged Chavez abused ...

How can an extension change hands with no oversight?

A buyer downsizing from a bungalow spent several months searching for a spacious condominium in either Point McKay or Parkdale along the Bow River. Last summer, she found this two-bedroom corner unit ...

The Hacker News is the top cybersecurity news platform, delivering real-time updates, threat intelligence, data breach ...

Merck & Co. is splitting its main pharmaceutical unit in two in an effort to better highlight the parts of the business that are growing, as it stares down a patent cliff for its best-selling cancer ...

Merck said on Monday it would split its business into two, creating ⁠a distinct division for its cancer franchise led by blockbuster drug Keytruda while grouping its non-oncology treatments separately ...

Merck to split business into oncology and non-oncology units Split does not involve its animal health division Key patents on Keytruda will begin to expire in 2028 Feb 23 (Reuters) - Merck (MRK.N), ...

Feb 23 (Reuters) - Merck said on ⁠Monday ⁠it would create a separate ⁠division for its cancer business, anchored by its top-selling drug Keytruda, as the U.S. drugmaker braces for the upcoming patent ...

Feb 23 (Reuters) – Merck said on Monday it would create a separate division for its cancer business, anchored by its top-selling drug Keytruda, as the U.S. drugmaker braces for the upcoming patent ...

Feb 23 (Reuters) - Merck is splitting its human-health business into two ‌divisions to offset pressures ‌related to the loss of patent for its top-selling drug Keytruda, the Wall Street Journal ...